View this email in your browser

Special Newsletter

Because of the current COVID-19 pandemic we would like to inform you about the effect of this situation on the services and external quality assessment programme of the ECAT Foundation. We kindly ask you to take a good look at this information.
Petra van Velp
ECAT office

As a result of governmental regulations, the daily occupation of the ECAT office will be reduced till April 28th.  We do the utmost to keep everything running as usual. However, due to the reduced occupancy, it may take some days more before we can respond to your emails.
Depending on further governmental regulations we probably have to extend this period. We will announce this at our website.
We apologise for any inconvience.

EQA Surveys 

The Survey Schedule for the first half year of 2020 has been modified. Below a summary of the changes is given:           
 Survey  Description  Survey period extended till
 2020-S1  Screen survey  30 April
 2020-D1  D-Dimer survey  30 April
 2020-M1  Main survey  30 April
 2020-L1  Lupus survey  30 April
 2020-A1  Anticoagulation survey  30 April
 2020-H1  Homocysteine survey  30 April
 2020-T1  ROTEM/TEG survey  30 April
    Original survey period
 2020-S2  Screen survey  11 – 15 May
 2020-D2  D-Dimer survey  15 – 23 June

The following surveys will be postponed until further notice:
2020-M2 (Main); 2020-L2 (Lupus), 2020-A2 (Anticoagulation), 2020-H2 (Homocysteine), 2020-P2 (PFA), 2020-TG2 (Thrombin generation), 2020-T2 (ROTEM/TEG).

As we do not currently know the duration of the COVID-19 crisis no information can be given yet about the expected start of the above mentioned surveys. We hope to resume our services as soon as we are able to do. We keep you informed.

ECAT Participants' Meeting 

We have decided to postpone our participants' Meeting, originally scheduled for 5 and 6 November 2020 to November 2021. The new dates for the symposium are 18 and 19 November 2021.


If you have any questions about the above mentioned information, please send an e-mail to the ECAT office:
April 2020, Issue 16
ECAT Foundation
ECAT Information
Diagnostic Corner
Pharma Corner
Editor in Chief:
P. van Velp

Editorial Board:
P. van Velp
P. Meijer

Advisory Committee:
E. van Cott
K. Devreese
D. Peetz
A. Stroobants

+31.(0)71.3030910 9
Copyright © 2020 ECAT Foundation, All rights reserved.
You have received this email as a participant of the ECAT EQA Programme

Our email address is:

Want to change how you receive these emails?
You can unsubscribe from this list